ORIQ:NASDAQOrigin Investment Corp I Analysis
Data as of 2026-04-22 - not real-time
$10.20
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
ORIQ trades at $10.20, sitting just above its 20‑day SMA (10.20) and 50‑day SMA (10.20), indicating price is flat. The RSI of 50.6 and MACD histogram slightly negative point to a neutral to mildly bearish momentum. Volume has slipped to an average of 2 shares versus a 10‑day average of 5,000, signaling dwindling liquidity. The stock’s beta of –0.02 suggests virtually no correlation with the market, but the 30‑day volatility of 1.58% is modest. However, the PE of 78.5 and price‑to‑book of 85 are dramatically higher than the industry PE average of 17.6, flagging severe overvaluation.
The company reports zero revenue, no earnings growth and negative operating cash flow, reinforcing the view that valuation is detached from fundamentals. With no dividend and a max drawdown of only 0.78%, downside protection is limited. The “Extreme Greed” market sentiment (fear‑greed index 87) may be inflating price temporarily. Given the decreasing volume, lack of operational traction, and inflated multiples, the actionable recommendation is to avoid new exposure and consider exiting existing positions. Investors should monitor any merger or acquisition announcements that could materially change the risk/reward profile.
The company reports zero revenue, no earnings growth and negative operating cash flow, reinforcing the view that valuation is detached from fundamentals. With no dividend and a max drawdown of only 0.78%, downside protection is limited. The “Extreme Greed” market sentiment (fear‑greed index 87) may be inflating price temporarily. Given the decreasing volume, lack of operational traction, and inflated multiples, the actionable recommendation is to avoid new exposure and consider exiting existing positions. Investors should monitor any merger or acquisition announcements that could materially change the risk/reward profile.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Neutral technicals with slight bearish MACD
- Extremely high valuation multiples
- Shrinking trading volume and liquidity
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Lack of revenue and cash flow generation
- Potential merger catalyst
- Continued overvaluation risk
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental deficiencies remain
- No dividend or earnings outlook
- Reliance on speculative SPAC‑type event
Key Metrics & Analysis
Financial Health
P/E Ratio78.5
ROE124.00%
ROA-1.17%
P/B Ratio85.0
Op. Cash Flow$-694714
Free Cash Flow$-170455
Industry P/E17.6
Technical Analysis
TrendNeutral
RSI50.6
Support$10.18
Resistance$10.22
MA 20$10.20
MA 50$10.20
MA 200$10.15
MACDBearish
VolumeDecreasing
Fear & Greed Index87.14
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-0.02
Volatility1.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.